Back

Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis

26 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Statins, bempedoic acid and ezetimibe: novel findings Cardiotoxicity of Drugs ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tommaso Bucci

University of Perugia, Perugia (Italy)

6 More presentations in this session

Presentation thumbnail
Strike Early and Strike Strong: application of a strategy comprising first-line combination of high-intensity statins and ezetimibe for patients with acute myocardial infarction in routine practice
Professor F. Schiele (Besancon, FR)
Abstract Slides Video
Presentation thumbnail
The impact of statin intensity on long-term outcomes in elderly patients with acute myocardial infarction who have undergone percutaneous coronary intervention
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial
Associate Professor S. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Improving statins effectiveness by targeting baseline LDL cholesterol in type 2 diabetes mellitus, a systematic review and meta-analysis
Mrs N. Soroush (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Therapeutic gaps in low-density lipoprotein cholesterol management have narrowed over time but remain wide: a wide study of 40,141 acute coronary syndrome patients from 2016 to 2021
Doctor G. Tan (Shatin, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Statins, bempedoic acid and ezetimibe: novel findings

The Event

Event poster

ESC Congress 2023

26 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Are statins preventive of cardiotoxicity in breast cancer patients treated with anthracyclines? A single center retrospective analysis
thumbnail
Congress Presentation
Cardioprotective role of statins in breast cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
thumbnail
Congress Presentation
Chemotherapy versus tumour burden: evaluating their roles in cardiovascular risk enhancement for breast cancer patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources